Rivaroxaban for Slow Coronary Flow After PCI in STEMI | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Rivaroxaban for Slow Coronary Flow After PCI in STEMI	Infarction, Necrosis, No-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder	Not yet recruiting	Phase 4	2025-09-29		NCT07195812

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Jiaxing University	36
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
The Second Affiliated Hospital of Jiaxing University	22
Wenzhou People's Hospital	4

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.